Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-institutional Study
Fabio Zattoni, Giorgio Gandaglia(Vita-Salute San Raffaele University), Roderick van den Bergh(European Association of Urology), Francesco Barletta(Vita-Salute San Raffaele University), Giancarlo Marra(Royal Free London NHS Foundation Trust), Junlong Zhuang(Nanjing Drum Tower Hospital), Paolo Gontero(Fondazione Ricerca Molinette), Hongqian Guo(Nanjing Drum Tower Hospital), Derya Tilki(Koç University), Alberto Briganti(University College London Hospitals NHS Foundation Trust), Alberto Martini(The University of Texas MD Anderson Cancer Center), Daniel Moon(Peter MacCallum Cancer Centre), Timothy J. Harkin(Cleveland Clinic), Veeru Kasivisvanathan(University College London Hospitals NHS Foundation Trust), Giacomo Novara(University of Padua), Massimo Valério(University Hospital of Geneva), Peter Ka‐Fung Chiu(Chinese University of Hong Kong), Alexander Kretschmer(Ludwig-Maximilians-Universität München), Alessandro Morlacco(University of Padua), Mark Frydenberg(Monash University), Isabel Heidegger(Innsbruck Medical University), Jonathan Olivier(Université de Lille), Jeremy Grummet(Alfred Health), Guillaume Ploussard(Yves Rocher (France)), Fabrizio Moro(University of Padua), Francesco Montorsi(Vita-Salute San Raffaele University), Alessandro Marquis(Azienda Ospedaliero Universitaria San Giovanni Battista)
Cited by 24
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656